| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Tuesday’s Close |
|---|---|---|---|---|---|
| ACN | Accenture plc | $171.04 | $109.71B | N/A |
IHS Markit (INFO) to Post Q4 Earnings: What's in the Offing?
http://www.zacks.com/stock/news/709639/ihs-markit-info-to-post-q4-earnings-whats-in-the-offing?cid=CS-ZC-FT-analyst_blog|earnings_preview-709639
Jan 09, 2020 - Strong segmental performance is likely to have driven IHS Markit's (INFO) top line in the fourth quarter of fiscal 2019.
0
Charles River Hires VP for Risk, Investigations & Analytics
http://www.zacks.com/stock/news/707758/charles-river-hires-vp-for-risk-investigations-analytics?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-707758
Jan 08, 2020 - Panes' expertise is expected to enhance the quality of the professional team that has helped Charles River (CRAI) achieve reputation of providing high-quality consulting services.
0
Republic Services Hits a New 52-Week High: What's Aiding It?
http://www.zacks.com/stock/news/706232/republic-services-hits-a-new-52-week-high-whats-aiding-it?cid=CS-ZC-FT-analyst_blog|52-week_high/low-706232
Jan 07, 2020 - Republic Services (RSG) stock benefits from consecutive better-than-expected bottom-line performance, encouraging 2019 adjusted earnings per share guidance and internal growth.
0
ACN: Wolfe Research ups to Peer Perform
https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=UD20200106091703
Jan 06, 2020 - Wolfe Research issues rating change for ACN
0
Here's Why You Should Hold on to ABM Industries (ABM) Stock
http://www.zacks.com/stock/news/704445/heres-why-you-should-hold-on-to-abm-industries-abm-stock?cid=CS-ZC-FT-analyst_blog|rank_focused-704445
Jan 06, 2020 - ABM Industries (ABM) continues to focus on optimizing revenue management, increasing client retention and improving labor management through process and technology.
0
S&P Global Touches a New 52-Week High: What's Aiding It?
http://www.zacks.com/stock/news/704444/sp-global-touches-a-new-52-week-high-whats-aiding-it?cid=CS-ZC-FT-analyst_blog|52-week_high/low-704444
Jan 06, 2020 - S&P Global (SPGI) stock benefits from consecutive better-than-expected top- and bottom-line performance, encouraging 2019 adjusted earnings per share guidance and acquisitions.
0
Here's How Accenture Plans to Keep the Good Times Rolling
https://www.fool.com/investing/2020/01/03/heres-how-accenture-plans-to-keep-the-good-times-r.aspx?source=iedfolrf0000001
Jan 03, 2020 - Sales rose 23% over the last three years while earnings climbed 30% higher. The next phase in the professional services titan's growth will come from a tight focus on local markets, backed by decades of global experience.
0
Mid-Day Market Update: Sol-Gel Surges Following Positive Acne-Study Data; Wave Life Sciences Shares Plunge
http://feeds.benzinga.com/~r/benzinga/~3/bHEQyChEVZI/mid-day-market-update-sol-gel-surges-following-positive-acne-study-data-wave-life-sciences-shares-p
Dec 30, 2019 -
Midway through trading Monday, the Dow traded down 0.64% to 28462.54 while the NASDAQ fell 0.90% to 8925.19. The S&P also fell, dropping 0.64% to 3,219.39.
0
CLGX vs. ACN: Which Stock Is the Better Value Option?
http://www.zacks.com/stock/news/686025/clgx-vs-acn-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-686025
Dec 24, 2019 - CLGX vs. ACN: Which Stock Is the Better Value Option?
0
Bausch's (BHC) Arazlo Gets FDA Approval for Acne Vulgaris
http://www.zacks.com/stock/news/679934/bauschs-bhc-arazlo-gets-fda-approval-for-acne-vulgaris?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-679934
Dec 20, 2019 - Bausch (BHC) gets FDA approval for Arazlo Lotion for the topical treatment of acne vulgaris in patients nine years of age or older.
0